Closed to new investors.
NAV Price ()
Number of stocks
Risk Indicator

About this fund

Fund objectives

  • The Fund seeks to provide long-term capital growth.
  • The Fund employs an “active management” strategy to invest mainly in U.S. stocks, with an emphasis on companies that are considered to have prospects for rapid earnings growth. The Fund’s Sub-Investment Manager, PRIMECAP Management Company (“PRIMECAP”), uses fundamental research to identify stocks that are expected to outperform the market over a three to five-year time horizon and that are available at attractive prices relative to their fundamental values. The Fund has the flexibility to invest in companies of any size, but it mostly invests in small and mid-cap stocks.
  • The Fund may measure performance against the Russell 3000 Index (the “Index”), a market-capitalisation-weighted stock market index, composed of the top 3,000 US publically traded companies, as ranked by market capitalisation, or the total dollar value of all outstanding shares. The Fund is not otherwise constrained by or managed with reference to the Index. The Index does not define the investment universe of the Fund and the composition of the Fund may deviate significantly from that of the Index.
  • The Fund’s policy is to remain substantially invested in common stocks that are listed or traded on exchanges or markets in the United States.

Fund facts

Share class inception
04 Dec 2006
Minimum initial investment
€100,000.00
Investment structure
Irish UCITS
Share Class Assets'
Total Assets
Strategy
Active
Asset Class
Equity
Domicile
Ireland
Dividend schedule
Tax status
Austria, Germany and Switzerland reporting
Currency
EUR
Legal entity
Vanguard Investment Series PLC
Investment manager

Vanguard Global Advisers, LLC
PRIMECAP Management Company

Benchmark
Russell 3000 Index

The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.

Performance

Risk and Volatility

As at 30 Sep 2025

Beta
Annualized Tracking Error
1 year
3 years
5 years

Please note Beta and R-squared data will only display for funds with 3 full years of history.

The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.

Portfolio data

Characteristics
FundamentalsFundBenchmarkAs at
Number of stocks 231 2,983 30 Sep 2025
Median market capital 21.9 B 205.3 B 30 Sep 2025
26.3 x 27.9 x 30 Sep 2025
3.8 x 4.6 x 30 Sep 2025
11.2% 23.8% 30 Sep 2025
16.7% 22.9% 30 Sep 2025
Portfolio turnover rate 16.6% 30 Sep 2025
Market allocation

As at 30 Sep 2025

CountryRegionFundBenchmarkVariance +/-
United States of AmericaNorth America 88.67% 99.28% -10.61%
ChinaEmerging Markets 6.04% 0.00% 6.04%
OtherOther 2.97% 0.41% 2.56%
CanadaNorth America 1.03% 0.00% 1.03%
GermanyEurope 0.50% 0.00% 0.50%
SwitzerlandEurope 0.37% 0.00% 0.37%
United KingdomEurope 0.20% 0.00% 0.20%
FranceEurope 0.15% 0.00% 0.15%
IsraelMiddle East 0.07% 0.00% 0.07%
ArgentinaEmerging Markets 0.00% 0.00% 0.00%
PanamaEmerging Markets 0.00% 0.00% 0.00%
BrazilEmerging Markets 0.00% 0.11% -0.11%
PeruEmerging Markets 0.00% 0.02% -0.02%
SingaporePacific 0.00% 0.00% 0.00%
Hong KongPacific 0.00% 0.00% 0.00%
Holdings details

As at 30 Sep 2025

Holding name% of market valueSectorRegionMarket valueShares
Eli Lilly & Co 3.64680% Health Care US €48,437,529.00 63,483
Micron Technology Inc 3.31171% Information Technology US €43,986,754.80 262,890
Xometry Inc 3.19097% Industrials US €42,383,107.00 778,100
Flex Ltd 2.99371% Information Technology US €39,763,072.25 685,925
NEXTracker Inc 2.60331% Industrials US €34,577,672.71 467,329
Alibaba Group Holding Ltd 2.33872% Consumer Discretionary US €31,063,274.00 173,800
Alphabet Inc 2.17528% Communication Services US €28,892,435.00 118,850
BeOne Medicines Ltd 2.09347% Health Care US €27,805,889.80 81,614
Raymond James Financial Inc 1.87050% Financials US €24,844,389.20 143,942
Rhythm Pharmaceuticals Inc 1.85218% Health Care US €24,600,962.02 243,598

Prices and distribution

Prices

NAV Price (EUR)
€2,028.59
Change
+€8.060.40%
At closure 29 Oct 2025
NAV 52-week high
€2,032.16
At closure 30 Oct 2025
NAV 52-week low
€1,395.20
At closure 30 Oct 2025
NAV 52-week difference
€636.97
Change
+31.34%
At closure 30 Oct 2025
Historical Prices

-

Inception date

04 Dec 2006

Date NAV (EUR)
29 Oct 2025 €2,028.5940
28 Oct 2025 €2,020.5373
27 Oct 2025 €2,032.1648
24 Oct 2025 €2,020.1377
23 Oct 2025 €1,997.7638
22 Oct 2025 €1,970.6626
21 Oct 2025 €1,993.4588
20 Oct 2025 €1,999.9907
17 Oct 2025 €1,960.1603
16 Oct 2025 €1,963.0303

Distribution history

Distribution frequency

Historical performance 30 Sep 2025

0.61%

All dividends are reinvested for the "Accumulation" shares.

Purchase information

Currency

Base currency: EUR

Fund codes

  • Bloomberg: VANGUOE
  • Citi: HRG4
  • ISIN: IE00B03HCV24
  • MEX ID: VIUSOP
  • SEDOL: B03HCV2